First test of new hives drug in healthy people
NCT ID NCT06294288
Summary
This early-stage study tested a new drug called LP-003 in healthy volunteers to see if it is safe and how the body processes it. The goal is to develop a treatment for chronic spontaneous urticaria, a condition causing long-lasting hives. Researchers gave single and multiple doses to 60 healthy adults to check for side effects and measure drug levels in the blood.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC SPONTANEOUS URTICARIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Shanghai General Hospital
Shanghai, Shanghai Municipality, China
Conditions
Explore the condition pages connected to this study.